3 Drug Stocks That Soared This Week: Are They Buys?
Most investors would be quite happy to get a 20% return over the course of a year. Of course "happy" wouldn't begin to describe the feeling of getting an even better return than that in just a week. But that's just what three drug stocks did over the last five days, with two of them achieving much-higher gains.
Endocyte (NASDAQ: ECYT), MannKind (NASDAQ: MNKD), and Mylan (NASDAQ: MYL) saw their stocks soar this week after floundering for much of 2017. Let's see why these drug stocks took off -- and whether they're smart picks for investors.
Image source: Getty Images.
Source: Fool.com
Teva Pharmaceutical Industries Ltd ADR Aktie
15,95 €
-0,93 %
Die Teva Pharmaceutical Industries Ltd ADR Aktie wird von der Community stark bevorzugt: Mehrere Buy-Einschätzungen, keine Sell-Einschätzungen.
Ein leicht positives Kursziel von 19 € für Teva Pharmaceutical Industries Ltd ADR gegenüber dem aktuellen Kurs von 15.95 € wird gesehen.
